Immediate Effect of Continuous Ultrasound vs Sham Ultrasound for Bilateral Masseter Myalgia: A Double-Blinded Trial

Aims: To investigate the local and segmental effects of therapeutic ultrasound at a dose of 0.4 w/cm2 with 100% duty cycle for 5 minutes compared to the effect of sham ultrasound on painful masticatory muscles. Methods: A total of 20 adult female subjects with bilateral masseter myalgia diagnosed according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) were included. Each subject was randomized to either an active ultrasound group or a sham ultrasound group. The intervention was applied to each masseter muscle for 5 minutes. Measures included pre- and post–self-reported pain intensity recorded on a verbal rating scale (VRS), pressure pain thresholds for the masseter (PPT-M) and temporalis (PPT-T) muscles, and intraoral temperature for the masseter muscle. Preintervention score was subtracted from the postintervention score for all measures to calculate mean change in pain, and nonparametric Mann-Whitney test was used to compare the groups. Statistical significance was set at P < .05. Results: Changes in VRS did not show a significant difference between groups (P > .05). There were significant increases in PPT-M and intraoral temperature in the ultrasound group compared to the sham group (P < .05). There was no significant difference in PPT-T (P > .05), suggesting no segmental effect. Conclusion: Therapeutic ultrasound produced an immediate increase in PPT-M and intraoral temperature compared to sham ultrasound in female subjects with bilateral masseter myalgia.

myalgia;TMD;ultrasound

1. Greene CS. Managing the care of patients with temporomandib- ular disorders: A new guideline for care. J Am Dent Assoc 2010; 141:1086–1088.

2. Sanders AE, Slade GD, Bair E, et al. General health status and incidence of first-onset temporomandibular disorder: The OP- PERA prospective cohort study. J Pain 2013;14(suppl):T51–T62.

3. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporoman- dibular disorders: A systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:453–462.

4. Bair E, Ohrbach R, Fillingim RB, et al. Multivariable modeling of phenotypic risk factors for first-onset TMD: The OPPERA prospective cohort study. J Pain 2013;14(suppl):T102–T115.

5. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 2014;28:6–27.

6. de Leeuw R, Klasser GD (eds). Diagnosis and management of TMDs. In: Orofacial Pain: Guidelines for Assessment, Diag- nosis, and Management, ed 5. Chicago: Quintessence, 2013: 127–186.

7. Allen RJ. Physical agents used in the management of chron- ic pain by physical therapists. Phys Med Rehabil Clin N Am 2006;17:315–345.

8. ter Haar G. Basic physics of therapeutic ultrasound. Physio- therapy 1978;64:100–103.

9. Draper DO, Schulthies S, Sorvisto P, Hautala AM. Temperature changes in deep muscles of humans during ice and ultrasound therapies: An in vivo study. J Orthop Sports Phys Ther 1995; 21:153–157.

10. Hsieh YL. Reduction in induced pain by ultrasound may be caused by altered expression of spinal neuronal nitric ox- ide synthase-producing neurons. Arch Phys Med Rehabil 2005;86:1311–1317.

11. Talaat AM, el-Dibany M, el-Garf A. Physical therapy in the man- agement of myofacial pain dysfunction syndrome. Ann Otol Rhi- nol Laryngol 1986;95:225–228.

12. Rai S, Ranjan V, Misra D, Panjwani S. Management of myofas- cial pain by therapeutic ultrasound and transcutaneous elec- trical nerve stimulation: A comparative study. Eur J Dent 2016; 10:46–53.

13. Robertson VJ. Dosage and treatment response in random- ized clinical trials of therapeutic ultrasound. Phys Ther Sport 2002;3:124–133.

14. Fadol Y. Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investiga- tional Trial. https://clinicaltrials.gov/ct2/show/NCT02295644. Accessed 2 April 2018.

15. Srbely JZ, Dickey JP, Lowerison M, Edwards AM, Nolet PS, Wong LL. Stimulation of myofascial trigger points with ultra- sound induces segmental antinociceptive effects: A random- ized controlled study. Pain 2008;139:260–266.

16. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity mea- sured on an 11-point numerical pain rating scale. Pain 2001; 94:149–158.

17. Ohrbach R, Crow H, Kamer A. Examiner expectancy effects in the measurement of pressure pain thresholds. Pain 1998; 74:163–170.

18. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: Recent advances and current thought. Annu Rev Psychol 2008;59:565–590.

19. Baker KG, Robertson VJ, Duck FA. A review of therapeutic ul- trasound: Biophysical effects. Phys Ther 2001;81:1351–1358.

20. Solomon J, Shebshacvich V, Adler R, Vulfsons S, Rosenbach A, Eisenberg E. The effects of TENS, heat, and cold on the pain thresholds induced by mechanical pressure in healthy volun- teers. Neuromodulation 2003;6:102–107.

21. Slade GD, Bair E, Greenspan JD, et al. Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: The OPPERA prospective cohort study. J Pain 2013;14(suppl):T20–T32.